Turn Therapeutics (TTRX) Shares Outstanding (2024 - 2026)

Turn Therapeutics' Shares Outstanding history runs 3 years deep, the most recent figure standing at $29.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 9.29% year-over-year to $29.8 million; the TTM figure through Mar 2026 stood at $29.8 million (up 9.29% YoY), while the FY2025 annual figure was $29.4 million, up 9.68% from the prior year.
• Shares Outstanding was $29.8 million for Q1 2026 at Turn Therapeutics, up from $29.4 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $29.8 million in Q1 2026 to a low of $26.7 million in Q3 2024.
• Historically, Shares Outstanding has averaged $28.0 million across 3 years, with a median of $27.6 million in 2025.
• Biggest YoY gain for Shares Outstanding was 9.68% in 2025; the steepest drop was 4.99% in 2025.
• A 3-year view of Shares Outstanding shows it stood at $26.8 million in 2024, then rose by 9.68% to $29.4 million in 2025, then rose by 1.16% to $29.8 million in 2026.
• The last three Shares Outstanding figures came in at $29.8 million (Q1 2026), $29.4 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.